Illumina forecasts flat 2024 sales as sluggish demand drags on
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Illumina (ILMN) PT Raised to $135 at JPMorgan
February 9, 2024 10:27 AM ESTJPMorgan analyst Rachel Vatnsdal raised the price target on Illumina (NASDAQ: ILMN) to $135.00 (from $110.00) while maintaining a Neutral rating.
The analyst comments "Illumina (ILMN) reported 4Q revenues of $1.12B in line with pre-announcement (+4% y/y reported, +4% cc) and above the then-consensus of $1.07B. The quarter was driven by 79 NovaSeq X shipments (vs. guide of ~62 guided at midpoint) bringing the total installed base to 352 instruments, paired with... More
